The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Oxycodone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oxycodone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oxycodone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oxycodone include Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Mallinckrodt and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oxycodone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxycodone.
Report Scope
The Oxycodone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxycodone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxycodone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Sanofi
Pfizer
Purdue Pharma
Endo International
Teva Pharmaceuticals
Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
Mallinckrodt
Mylan
Sun Pharmaceutical (Chattem Chemicals)
Impax Laboratories
Indivior
Segment by Type
Long Acting Oxycodone
Short Acting Oxycodone
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxycodone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oxycodone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oxycodone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oxycodone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oxycodone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oxycodone include Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Mallinckrodt and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oxycodone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxycodone.
Report Scope
The Oxycodone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxycodone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxycodone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Sanofi
Pfizer
Purdue Pharma
Endo International
Teva Pharmaceuticals
Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
Mallinckrodt
Mylan
Sun Pharmaceutical (Chattem Chemicals)
Impax Laboratories
Indivior
Segment by Type
Long Acting Oxycodone
Short Acting Oxycodone
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxycodone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oxycodone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oxycodone Market Overview
1.1 Product Overview and Scope of Oxycodone
1.2 Oxycodone Segment by Type
1.2.1 Global Oxycodone Market Value Comparison by Type (2024-2030)
1.2.2 Long Acting Oxycodone
1.2.3 Short Acting Oxycodone
1.3 Oxycodone Segment by Application
1.3.1 Global Oxycodone Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Global Oxycodone Market Size Estimates and Forecasts
1.4.1 Global Oxycodone Revenue 2019-2030
1.4.2 Global Oxycodone Sales 2019-2030
1.4.3 Global Oxycodone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oxycodone Market Competition by Manufacturers
2.1 Global Oxycodone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oxycodone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oxycodone Average Price by Manufacturers (2019-2024)
2.4 Global Oxycodone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oxycodone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oxycodone, Product Type & Application
2.7 Oxycodone Market Competitive Situation and Trends
2.7.1 Oxycodone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oxycodone Players Market Share by Revenue
2.7.3 Global Oxycodone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oxycodone Retrospective Market Scenario by Region
3.1 Global Oxycodone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oxycodone Global Oxycodone Sales by Region: 2019-2030
3.2.1 Global Oxycodone Sales by Region: 2019-2024
3.2.2 Global Oxycodone Sales by Region: 2025-2030
3.3 Global Oxycodone Global Oxycodone Revenue by Region: 2019-2030
3.3.1 Global Oxycodone Revenue by Region: 2019-2024
3.3.2 Global Oxycodone Revenue by Region: 2025-2030
3.4 North America Oxycodone Market Facts & Figures by Country
3.4.1 North America Oxycodone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oxycodone Sales by Country (2019-2030)
3.4.3 North America Oxycodone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oxycodone Market Facts & Figures by Country
3.5.1 Europe Oxycodone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oxycodone Sales by Country (2019-2030)
3.5.3 Europe Oxycodone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oxycodone Market Facts & Figures by Country
3.6.1 Asia Pacific Oxycodone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oxycodone Sales by Country (2019-2030)
3.6.3 Asia Pacific Oxycodone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oxycodone Market Facts & Figures by Country
3.7.1 Latin America Oxycodone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oxycodone Sales by Country (2019-2030)
3.7.3 Latin America Oxycodone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oxycodone Market Facts & Figures by Country
3.8.1 Middle East and Africa Oxycodone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oxycodone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oxycodone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oxycodone Sales by Type (2019-2030)
4.1.1 Global Oxycodone Sales by Type (2019-2024)
4.1.2 Global Oxycodone Sales by Type (2025-2030)
4.1.3 Global Oxycodone Sales Market Share by Type (2019-2030)
4.2 Global Oxycodone Revenue by Type (2019-2030)
4.2.1 Global Oxycodone Revenue by Type (2019-2024)
4.2.2 Global Oxycodone Revenue by Type (2025-2030)
4.2.3 Global Oxycodone Revenue Market Share by Type (2019-2030)
4.3 Global Oxycodone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oxycodone Sales by Application (2019-2030)
5.1.1 Global Oxycodone Sales by Application (2019-2024)
5.1.2 Global Oxycodone Sales by Application (2025-2030)
5.1.3 Global Oxycodone Sales Market Share by Application (2019-2030)
5.2 Global Oxycodone Revenue by Application (2019-2030)
5.2.1 Global Oxycodone Revenue by Application (2019-2024)
5.2.2 Global Oxycodone Revenue by Application (2025-2030)
5.2.3 Global Oxycodone Revenue Market Share by Application (2019-2030)
5.3 Global Oxycodone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Oxycodone Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Oxycodone Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Oxycodone Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Purdue Pharma
6.4.1 Purdue Pharma Corporation Information
6.4.2 Purdue Pharma Description and Business Overview
6.4.3 Purdue Pharma Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Purdue Pharma Oxycodone Product Portfolio
6.4.5 Purdue Pharma Recent Developments/Updates
6.5 Endo International
6.5.1 Endo International Corporation Information
6.5.2 Endo International Description and Business Overview
6.5.3 Endo International Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Endo International Oxycodone Product Portfolio
6.5.5 Endo International Recent Developments/Updates
6.6 Teva Pharmaceuticals
6.6.1 Teva Pharmaceuticals Corporation Information
6.6.2 Teva Pharmaceuticals Description and Business Overview
6.6.3 Teva Pharmaceuticals Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceuticals Oxycodone Product Portfolio
6.6.5 Teva Pharmaceuticals Recent Developments/Updates
6.7 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
6.6.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Corporation Information
6.6.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Description and Business Overview
6.6.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio
6.7.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Developments/Updates
6.8 Mallinckrodt
6.8.1 Mallinckrodt Corporation Information
6.8.2 Mallinckrodt Description and Business Overview
6.8.3 Mallinckrodt Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mallinckrodt Oxycodone Product Portfolio
6.8.5 Mallinckrodt Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Oxycodone Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Sun Pharmaceutical (Chattem Chemicals)
6.10.1 Sun Pharmaceutical (Chattem Chemicals) Corporation Information
6.10.2 Sun Pharmaceutical (Chattem Chemicals) Description and Business Overview
6.10.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio
6.10.5 Sun Pharmaceutical (Chattem Chemicals) Recent Developments/Updates
6.11 Impax Laboratories
6.11.1 Impax Laboratories Corporation Information
6.11.2 Impax Laboratories Oxycodone Description and Business Overview
6.11.3 Impax Laboratories Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Impax Laboratories Oxycodone Product Portfolio
6.11.5 Impax Laboratories Recent Developments/Updates
6.12 Indivior
6.12.1 Indivior Corporation Information
6.12.2 Indivior Oxycodone Description and Business Overview
6.12.3 Indivior Oxycodone Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Indivior Oxycodone Product Portfolio
6.12.5 Indivior Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oxycodone Industry Chain Analysis
7.2 Oxycodone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oxycodone Production Mode & Process
7.4 Oxycodone Sales and Marketing
7.4.1 Oxycodone Sales Channels
7.4.2 Oxycodone Distributors
7.5 Oxycodone Customers
8 Oxycodone Market Dynamics
8.1 Oxycodone Industry Trends
8.2 Oxycodone Market Drivers
8.3 Oxycodone Market Challenges
8.4 Oxycodone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
